A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers

NCT00608699 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Dyslipidaemias

Interventions

DRUG: GSK256073A tablets + IR niacin tablets

Sponsor

GlaxoSmithKline